Allergan is still trading more than 11% below the merger consideration offered by AbbVie. AbbVie shareholders can earn 17% on cash by selling some of their ...
AbbVie Shareholders Can Earn 17% On Excess Cash Through Merger Arbitrage - Seeking Alpha
Read More
Bagikan Berita Ini
0 Response to "AbbVie Shareholders Can Earn 17% On Excess Cash Through Merger Arbitrage - Seeking Alpha"
Post a Comment